Menu
Back to Journals » Journal of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
Editor-in-Chief: Dr Ahmed Kaseb
The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal.
The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (628)
- Volume 11, 2024 (104)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Latest articles:
- 5 records -
Comparisons of Percutaneous Ablation, Open or Laparoscopic Liver Resection for Barcelona Clinic Liver Cancer Stage 0-A Hepatocellular Carcinoma: A Concurrent Generalized Propensity Score Analysis
Chen ZH, Zhou Q, Chen ZB, Xie WX, Song ZM, Lin SR, Wang W, Shen SL, Kuang M
Journal of Hepatocellular Carcinoma 2024, 11:1459-1472
Published Date: 25 July 2024
MRI Radiomics Combined with Clinicopathological Factors for Predicting 3-Year Overall Survival of Hepatocellular Carcinoma After Hepatectomy
Kuang F, Gao Y, Zhou Q, Lu C, Lin Q, Al Mamun A, Pan J, Shi S, Tu C, Shao C
Journal of Hepatocellular Carcinoma 2024, 11:1445-1457
Published Date: 18 July 2024
Why Liver Cancer Hits Home: Bridging Healthcare Disparities in the Asian American and Pacific Islander Community
Li D, Cheng S, Wilson Woods A, Luong A, Schiltz S, Tan R, Chi ZH
Journal of Hepatocellular Carcinoma 2024, 11:1439-1444
Published Date: 18 July 2024
Research Progress in Predicting Hepatocellular Carcinoma with Portal Vein Tumour Thrombus in the Era of Artificial Intelligence
Li Y, Fan N, He X, Zhu J, Zhang J, Lu L
Journal of Hepatocellular Carcinoma 2024, 11:1429-1438
Published Date: 17 July 2024
Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study
Liu G, Zhu D, He Q, Zhou C, He L, Li Z, Jiang Z, Huang M, Chang B, Wu C
Journal of Hepatocellular Carcinoma 2024, 11:1415-1428
Published Date: 12 July 2024